SEC Form SC 13G/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

2/28/22 8:38:55 AM ET

$AIH

Medical Specialities

Health Care

Get the next $AIH alert in real time by email

SC 13G/A 1 dp168085_sc13ga.htm FORM SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Aesthetic Medical International Holdings Group Limited

(Name of Issuer)

Ordinary shares, par value US$0.001 per share

(Title of Class of Securities)

00809M104**

(CUSIP Number)

December 31, 2021

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

o Rule 13d-1(c)

þRule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

** CUSIP number 00809M104 has been assigned to the American Depositary Shares (“ADSs”) of the Issuer, which are listed on the Nasdaq Global Market under the symbol “AIH.” Each ADS represents three ordinary shares, par value US$0.001 per share.

CUSIP No.

00809M104

1.	Names of Reporting Persons IDG-Accel China Growth Fund III L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 1,109,601 ordinary shares ⁽¹⁾
	6.	Shared Voting Power 1,266,921 ordinary shares ⁽²⁾
	7.	Sole Dispositive Power 1,109,601 ordinary shares ⁽¹⁾
	8.	Shared Dispositive Power 1,266,921 ordinary shares ⁽²⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽³⁾
12.	Type of Reporting Person (See Instructions) PN

(1) The reporting person is the record owner of these shares. By virtue of being the general partner of the reporting person, IDG-Accel China Growth Fund III Associates L.P. may be deemed to have sole voting and dispositive power with respect to these shares. By virtue of being the general partner of IDG-Accel China Growth Fund III Associates L.P., IDG-Accel China Growth Fund GP III Associates Ltd. may be deemed to have sole voting and dispositive power with respect to these shares. By virtue of being shareholders and the two directors of IDG-Accel China Growth Fund GP III Associates Ltd., Quan Zhou and Chi Sing Ho may be deemed to have shared voting and dispositive power with respect to these shares. IDG-Accel China Growth Fund GP III Associates Ltd. is also the general partner of IDG-Accel China III Investors L.P., which may be deemed to have shared voting and dispositive power with respect to these shares. Quan Zhou and Chi Sing Ho are the controlling persons of IDG Technology Venture Investment IV, LLC, which is the general partner of IDG Technology Venture Investment IV, L.P. By virtue of such relationships, each of IDG Technology Venture Investment IV, L.P. and IDG Technology Venture Investment IV, LLC may be deemed to have shared voting and dispositive power with respect to these shares.

(2) IDG-Accel China III Investors L.P. and IDG Technology Venture Investment IV, L.P. are the record owners of these shares. The reporting person and these entities have the same ultimate general partner or controlling persons. By virtue of such relationships, the reporting person may be deemed to share the voting and dispositive power with respect to these shares.

(3) Percent of class is calculated based on an aggregate of 70,793,671 ordinary shares outstanding as of December 31, 2020, as disclosed in the Issuer’s annual report on Form 20-F filed with the Securities and Exchange Commission on April 30, 2021.

CUSIP No.

00809M104

1.	Names of Reporting Persons IDG-Accel China Growth Fund III Associates L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 1,109,601 ordinary shares ⁽¹⁾
	6.	Shared Voting Power 1,266,921 ordinary shares ⁽²⁾
	7.	Sole Dispositive Power 1,109,601 ordinary shares ⁽¹⁾
	8.	Shared Dispositive Power 1,266,921 ordinary shares ⁽²⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽³⁾
12.	Type of Reporting Person (See Instructions) PN

(1) IDG-Accel China Growth Fund III L.P. is the record owner of these shares. By virtue of being the general partner of IDG-Accel China Growth Fund III L.P., the reporting person may be deemed to have sole voting and dispositive power with respect to these shares.

CUSIP No.

00809M104

1.	Names of Reporting Persons IDG-Accel China III Investors L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 78,663 ordinary shares ⁽¹⁾
	6.	Shared Voting Power 2,297,859 ordinary shares ⁽²⁾
	7.	Sole Dispositive Power 78,663 ordinary shares ⁽¹⁾
	8.	Shared Dispositive Power 2,297,859 ordinary shares ⁽²⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽³⁾
12.	Type of Reporting Person (See Instructions) PN

(1) The reporting person is the record owner of these shares. By virtue of being the general partner of the reporting person, IDG-Accel China Growth Fund GP III Associates Ltd. may be deemed to have sole voting and dispositive power with respect to these shares. By virtue of being shareholders and the two directors of IDG-Accel China Growth Fund GP III Associates Ltd., Quan Zhou and Chi Sing Ho may be deemed to have shared voting and dispositive power with respect to these shares. IDG-Accel China Growth Fund GP III Associates Ltd. is also the general partner of IDG-Accel China Growth Fund III Associates L.P., which is the general partner of IDG-Accel China Growth Fund III L.P. Quan Zhou and Chi Sing Ho are the controlling persons of IDG Technology Venture Investment IV, LLC, which is the general partner of IDG Technology Venture Investment IV, L.P. By virtue of such relationships, each of IDG-Accel China Growth Fund III Associates L.P., IDG-Accel China Growth Fund III L.P., IDG Technology Venture Investment IV, L.P. and IDG Technology Venture Investment IV, LLC may be deemed to have shared voting and dispositive power with respect to these shares.

(2) IDG-Accel China Growth Fund III L.P. and IDG Technology Venture Investment IV, L.P. are the record owners of these shares. The reporting person and these entities have the same ultimate general partner or controlling persons. By virtue of such relationships, the reporting person may be deemed to share the voting and dispositive power with respect to these shares.

CUSIP No.

00809M104

1.	Names of Reporting Persons IDG-Accel China Growth Fund GP III Associates Ltd.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 1,188,264 ordinary shares ⁽¹⁾
	6.	Shared Voting Power 1,188,258 ordinary shares ⁽²⁾
	7.	Sole Dispositive Power 1,188,264 ordinary shares ⁽¹⁾
	8.	Shared Dispositive Power 1,188,258 ordinary shares ⁽²⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽³⁾
12.	Type of Reporting Person (See Instructions) CO

(1) IDG-Accel China Growth Fund III L.P. and IDG-Accel China III Investors L.P. are the record owners of these shares. The reporting person is the general partner of IDG-Accel China III Investors L.P. and IDG-Accel China Growth Fund III Associates L.P., which is the general partner of IDG-Accel China Growth Fund III L.P. By virtue of such relationships, the reporting person may be deemed to have sole voting and dispositive power with respect to these shares.

(2) IDG Technology Venture Investment IV, L.P. is the record owners of these shares. The reporting person, IDG Technology Venture Investment IV, L.P., has the same ultimate controlling persons. By virtue of such relationship, the reporting person may be deemed to share the voting and dispositive power with respect to these shares.

CUSIP No.

00809M104

1.	Names of Reporting Persons IDG Technology Venture Investment IV, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 1,188,258 ordinary shares ⁽¹⁾
	6.	Shared Voting Power 1,188,264 ordinary shares ⁽²⁾
	7.	Sole Dispositive Power 1,188,258 ordinary shares ⁽¹⁾
	8.	Shared Dispositive Power 1,188,264 ordinary shares ⁽²⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽³⁾
12.	Type of Reporting Person (See Instructions) PN

(1) The reporting person is the record owner of these shares. By virtue of being the general partner of the reporting person, IDG Technology Venture Investment IV, LLC may be deemed to have sole voting and dispositive power with respect to these shares. By virtue of being the controlling persons of IDG Technology Venture Investment IV, LLC , Quan Zhou and Chi Sing Ho may be deemed to have shared voting and dispositive power with respect to these shares. Quan Zhou and Chi Sing Ho are also shareholders and the two directors of IDG-Accel China Growth Fund GP III Associates Ltd., which is the general partner of IDG-Accel China III Investors L.P. and IDG-Accel China Growth Fund III Associates L.P., which in turn is the general partner of IDG-Accel China Growth Fund III L.P. By virtue of such relationships, each of IDG-Accel China Growth Fund GP III Associates Ltd., IDG-Accel China III Investors L.P., IDG Accel China Growth Fund III Associates L.P. and IDG-Accel China Growth Fund III L.P. may be deemed to have shared voting and dispositive power with respect to these shares.

(2) IDG-Accel China Growth Fund III L.P. and IDG-Accel China III Investors L.P. are the record owners of these shares. The reporting person and these entities have the same ultimate controlling persons. By virtue of such relationship, the reporting person may be deemed to share the voting and dispositive power with respect to these shares.

CUSIP No.

00809M104

1.	Names of Reporting Persons IDG Technology Venture Investment IV, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 1,188,258 ordinary shares ⁽¹⁾
	6.	Shared Voting Power 1,188,264 ordinary shares ⁽²⁾
	7.	Sole Dispositive Power 1,188,258 ordinary shares ⁽¹⁾
	8.	Shared Dispositive Power 1,188,264 ordinary shares ⁽²⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽³⁾
12.	Type of Reporting Person (See Instructions) OO

(1) IDG Technology Venture Investment IV, L.P. is the record owner of these shares. By virtue of being the general partner of IDG Technology Venture Investment IV, L.P., the reporting person may be deemed to have sole voting and dispositive power with respect to these shares.

CUSIP No.

00809M104

1.	Names of Reporting Persons Quan Zhou
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization The United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power 0 ordinary shares
	6.	Shared Voting Power 2,376,522 ordinary shares ⁽¹⁾
	7.	Sole Dispositive Power 0 ordinary shares
	8.	Shared Dispositive Power 2,376,522 ordinary shares ⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽²⁾
12.	Type of Reporting Person (See Instructions) IN

(1) Including 1,188,258 ordinary shares of which the record owner is IDG Technology Venture Investment IV, L.P., 1,109,601 ordinary shares of which the record owner is IDG-Accel China Growth Fund III L.P., and 78,663 ordinary shares of which the record owner is IDG-Accel China III Investors L.P. The general partner of IDG-Accel China Growth Fund III L.P. is IDG-Accel China Growth Fund III Associates L.P., of which the general partner is IDG-Accel China Growth Fund GP III Associates Ltd., of which the reporting person and Chi Sing Ho are shareholders and the two directors. IDG-Accel China Growth Fund GP III Associates Ltd. is also the general partner of IDG-Accel China III Investors L.P. The general partner of IDG Technology Venture Investment IV, L.P. is IDG Technology Venture Investment IV, LLC. The reporting person and Chi Sing Ho are the controlling persons of IDG Technology Venture Investment IV, LLC. By virtue of such relationships, the reporting person may be deemed to have shared voting and dispositive power with respect to these shares.

(2) Percent of class is calculated based on an aggregate of 70,793,671 ordinary shares outstanding as of December 31, 2020, as disclosed in the Issuer’s annual report on Form 20-F filed with the Securities and Exchange Commission on April 30, 2021.

CUSIP No.

00809M104

1.	Names of Reporting Persons Chi Sing Ho
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Canada

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

Sole Voting Power

0 ordinary shares

Shared Voting Power

2,376,522 ordinary shares ⁽¹⁾

Sole Dispositive Power

0 ordinary shares

Shared Dispositive Power

2,376,522 ordinary shares ⁽¹⁾

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 2,376,522 ordinary shares
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
11.	Percent of Class Represented by Amount in Row (9) 3.4% ⁽²⁾
12.	Type of Reporting Person (See Instructions) IN

(1) Including 1,188,258 ordinary shares of which the record owner is IDG Technology Venture Investment IV, L.P., 1,109,601 ordinary shares of which the record owner is IDG-Accel China Growth Fund III L.P., and 78,663 ordinary shares of which the record owner is IDG-Accel China III Investors L.P. The general partner of IDG-Accel China Growth Fund III L.P. is IDG-Accel China Growth Fund III Associates L.P., of which the general partner is IDG-Accel China Growth Fund GP III Associates Ltd., of which the reporting person and Quan Zhou are shareholders and the two directors. IDG-Accel China Growth Fund GP III Associates Ltd. is also the general partner of IDG-Accel China III Investors L.P. The general partner of IDG Technology Venture Investment IV, L.P. is IDG Technology Venture Investment IV, LLC. The reporting person and Quan Zhou are the controlling persons of IDG Technology Venture Investment IV, LLC. By virtue of such relationships, the reporting person may be deemed to have shared voting and dispositive power with respect to these shares.

Item 1(a). Name of Issuer

Aesthetic Medical International Holdings Group Limited

Item 1(b). Address of Issuer’s Principal Executive Offices

1122 Nanshan Boulevard

Nanshan District, Shenzhen

Guangdong Province, China 518052

Item 2(a). Name of Persons Filing

	1.	IDG-Accel China Growth Fund III L.P.

	2.	IDG-Accel China Growth Fund III Associates L.P.

	3.	IDG-Accel China III Investors L.P.

	4.	IDG-Accel China Growth Fund GP III Associates Ltd.

	5.	IDG Technology Venture Investment IV, L.P.

	6.	IDG Technology Venture Investment IV, LLC

	7.	Quan Zhou

	8.	Chi Sing Ho

Item 2(b). Address of Principal Business Office or, If None, Residence

For all reporting persons:

c/o IDG Capital Management (HK) Limited.

Unit 5505, The Center

99 Queen’s Road Central

Hong Kong

Item 2(c). Citizenship

Quan Zhou is a citizen of the United States of America. Chi Sing Ho is a citizen of Canada. Each of IDG-Accel China Growth Fund III L.P., IDG-Accel China Growth Fund III Associates L.P., IDG-Accel China III Investors L.P. and IDG-Accel China Growth Fund GP III Associates Ltd. is organized under the laws of the Cayman Islands. Each of IDG Technology Venture Investment IV, L.P. and IDG Technology Venture Investment IV, LLC is organized under the laws of the State of Delaware.

Item 2(d). Title of Class of Securities

Ordinary shares, US$0.001 par value per share

Item 2(e). CUSIP Number

CUSIP number 00809M104 has been assigned to ADSs of the Issuer.

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

(a)

o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

o An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

(f)

o An employee benefit plan or endowment fund in accordance with Rule 13d–1(b)(1)(ii)(F);

(g)

o A parent holding company or control person in accordance with Rule 13d–1(b)(1)(ii)(G);

(h)

o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

o A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

(k)

o Group, in accordance with Rule 13d–1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J), please specify the type of institution: ____.

N/A.

Item 4. Ownership.

The information for each reporting person contained in Items 5-11 of the cover pages is incorporated herein by reference.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. ☒.

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

N/A.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

N/A.

Item 8. Identification and Classification of Members of the Group.

N/A.

Item 9. Notice of Dissolution of Group.

N/A.

Item 10. Certifications.

N/A.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 28, 2022

	IDG-Accel China Growth Fund III L.P. By: IDG-Accel China Growth Fund III Associates L.P., its General Partner By: IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China Growth Fund III Associates L.P.


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory


	IDG-Accel China III Investors L.P. By: IDG-Accel China Growth Fund GP III Associates Ltd., its General Partner


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory


	IDG Technology Venture Investment IV, L.P. By: IDG Technology Venture Investment IV, LLC its General Partner


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	IDG-Accel China Growth Fund III Associates L.P. By: IDG-Accel China Growth Fund GP III Associates Ltd., its General Partner


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory


	IDG-Accel China Growth Fund GP III Associates Ltd.


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory


	IDG Technology Venture Investment IV, LLC


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory


	QUAN ZHOU

	/s/ Quan Zhou


	CHI SING HO

	/s/ Chi Sing Ho

Exhibit 1

Joint Filing Agreement

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree (i) to the joint filing, on behalf of each of them, of a statement on Schedule 13G (including amendments thereto) with respect to ordinary shares, par value US$0.001 per share of Aesthetic Medical International Holdings Group Limited, a Cayman Islands company; and (ii) that this joint filing agreement may be included as an Exhibit to such joint filing. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.

Dated: February 28, 2022

	IDG-Accel China Growth Fund III L.P. By: IDG-Accel China Growth Fund III Associates L.P., its General Partner By: IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China Growth Fund III Associates L.P.


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	IDG-Accel China III Investors L.P. By: IDG-Accel China Growth Fund GP III Associates Ltd., its General Partner


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	IDG Technology Venture Investment IV, L.P. By: IDG Technology Venture Investment IV, LLC its General Partner


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	IDG-Accel China Growth Fund III Associates L.P. By: IDG-Accel China Growth Fund GP III Associates Ltd., its General Partner


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	IDG-Accel China Growth Fund GP III Associates Ltd.


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	IDG Technology Venture Investment IV, LLC


	By:	/s/ Quan Zhou
		Name: Quan Zhou
		Title: Authorized Signatory

	QUAN ZHOU

	/s/ Quan Zhou

	CHI SING HO

	/s/ Chi Sing Ho

Get the next $AIH alert in real time by email

SEC Form SC 13G/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

Chat with this insight

Recent Analyst Ratings for
$AIH

$AIH
Press Releases

Fastest customizable press release news feed in the world

Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

$AIH
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13D/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

SEC Form SC 13D/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

SEC Form SC 13D/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

$AIH
Financials

Live finance-specific insights

Aesthetic Medical International to Announce First Quarter 2023 Unaudited Financial Results on May 17, 2023

Aesthetic Medical International to Announce FY2022 Annual Report on April 21, 2023

Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results

$AIH
SEC Filings

SEC Form 6-K filed by Aesthetic Medical International Holdings Group Ltd.

SEC Form 6-K filed by Aesthetic Medical International Holdings Group Ltd.

SEC Form 20-F filed by Aesthetic Medical International Holdings Group Ltd.

$AIH
Leadership Updates

Live Leadership Updates

Aesthetic Medical International Announces Change of Auditor and Change of Director

Aesthetic Medical International and Investors Entered into a Share Purchase Agreement, a Subscription Agreement, a Shareholders' Agreement and a Cooperation Agreement

Aesthetic Medical International Holdings Group Limited Announces Change in Certified Public Accountant

SEC Form SC 13G/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

Chat with this insight

Recent Analyst Ratings for $AIH

$AIH Press Releases

Fastest customizable press release news feed in the world

Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

$AIH Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13D/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

SEC Form SC 13D/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

SEC Form SC 13D/A filed by Aesthetic Medical International Holdings Group Ltd. (Amendment)

$AIH Financials

Live finance-specific insights

Aesthetic Medical International to Announce First Quarter 2023 Unaudited Financial Results on May 17, 2023

Aesthetic Medical International to Announce FY2022 Annual Report on April 21, 2023

Aesthetic Medical International Reports Third Quarter 2022 Unaudited Financial Results

$AIH SEC Filings

SEC Form 6-K filed by Aesthetic Medical International Holdings Group Ltd.

SEC Form 6-K filed by Aesthetic Medical International Holdings Group Ltd.

SEC Form 20-F filed by Aesthetic Medical International Holdings Group Ltd.

$AIH Leadership Updates

Live Leadership Updates

Aesthetic Medical International Announces Change of Auditor and Change of Director

Aesthetic Medical International and Investors Entered into a Share Purchase Agreement, a Subscription Agreement, a Shareholders' Agreement and a Cooperation Agreement

Aesthetic Medical International Holdings Group Limited Announces Change in Certified Public Accountant

Recent Analyst Ratings for
$AIH

$AIH
Press Releases

$AIH
Large Ownership Changes

$AIH
Financials

$AIH
SEC Filings

$AIH
Leadership Updates